Dulanermin in cancer therapy: still much to do

Documenti analoghi

• Bone Targeted Therapy in Breast Cancer – an Old Concept but Still Much to Do
  di: Huober, Jens, et al.
  Pubblicazione: (2014)
• Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do
  di: Engels, E. A.
  Pubblicazione: (2017)
• Long non coding RNAs and ALS: Still much to do
  di: Gagliardi, Stella, et al.
  Pubblicazione: (2018)
• Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches
  di: Serrano, Davide, et al.
  Pubblicazione: (2014)
• Declining childhood and adolescent cancer mortality: Great progress but still much to be done
  Pubblicazione: (2014)